Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease

NCT06272630 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Liver Disease

Interventions

DRUG: DWJ1464
DRUG: Placebo of DWJ1464

Sponsor

Daewoong Pharmaceutical Co. LTD.